The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response

European Journal of Immunology

Volumn 28, Issue 5, 1998, Pages 1544-1553

  D'Orazio, Thomas J ^a   Niederkorn, Jerry Y ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cytokine; Macrophage; Monocyte; Rodent; Suppression; Th1 Th2; Tolerance

Indexed keywords

ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; LATEX; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HELPER CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40;

ANIMALS; ANTERIOR CHAMBER; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, VIRAL, TUMOR; CYTOKINES; INJECTIONS; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MICE, TRANSGENIC; OVALBUMIN; PARTICLE SIZE; SIMIAN VIRUS 40; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0031946530     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199805)28:05<1544::AID-IMMU1544>3.0.CO;2-P     Document Type: Article

References (35)

1. Niederkorn, J. Y., Immune privilege and immune regulation in the eye. Adv. Immunol. 1990. 48: 191-226.
2. Medawar, P., Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 1948. 29: 58-69.
3. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. and Ferguson, T. A., Fas ligand-induced apoptosis as a mechanism of immune privilege [see comments]. Science 1995. 270: 1189-1192.
4. Gery, I. and Streilein, J. W., Autoimmunity in the eye and its regulation. Curr. Opin. Immunol. 1994. 6: 938-945.
5. Wetzig, R. P., Foster, C. S. and Greene, M. I., Ocular immune responses. I. Priming of A/J mice in the anterior chamber with azobenzenearsonate-derivatized cells induces second-order-like suppressor T cells. J. Immunol. 1982. 128: 1753-1757.
6. Streilein, J. W., Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 1993. 5: 428-432.
7. Streilein, J. W., Wilbanks, G. A. and Cousins, S. W., Immunoregulatory mechanisms of the eye. J. Neuroimmunol. 1992. 39: 185-200.
8. Benson, J. L. and Niederkorn, J. Y., In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber. Immunology 1991. 74: 153-159.
9. Knisely, T. L., Luckenbach, M. W., Fischer, B. J. and Niederkorn, J. Y., Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J. Immunol. 1987. 138: 4515-4523.
10. Niederkorn, J. Y. and Meunier, P. C., Spontaneous immune rejection of intraocular tumors in mice. Invest. Ophthalmol. Vis. Sci. 1985. 26: 877-884.
11. Niederkorn, J. Y. and Knisely, T. L., Immunological analysis of a destructive pattern of intraocular tumor resolution. Curr. Eye. Res. 1988. 7: 515-526.
12. Knisely, T. L. and Niederkorn, J. Y., Immunologic evaluation of spontaneous regression of an intraocular murine melanoma. Invest. Ophthalmol. Vis. Sci. 1990. 31: 247-257.
13. Niederkorn, J. Y., The immunopathology of intraocular tumour rejection. Eye 1991. 5: 186-192.
14. Niederkorn, J. Y., Benson, J. L. and Mayhew, E., Efferent blockade of delayed-type hypersensitivity responses in the anterior chamber of the eye. Reg. Immunol. 1990. 3: 349-354.
15. Ma, D., Comerford, S., Bellingham, D., Sambrook, J., Gething, M. J., Alizadeh, H., Anand, R., Mellon, J. and Niederkorn, J. Y., Capacity of simian virus 40 T antigen to induce self-tolerance but not immunological privilege in the anterior chamber of the eye. Transplantation 1994. 57: 718-725.
16. Kielty, D., Cousins, S. W. and Atherton, S. S., HSV-1 retinitis and delayed hypersensitivity in DBA/2 and C57BL/6 mice. Invest. Ophthalmol. Vis. Sci. 1987. 28: 1994-1999.
17. Li, X. Y. and Niederkorn, J. Y., Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes. Ocular Immunol. Inflamm. 1997. 5: in press.
18. Gajewski, T. F. and Fitch, F. W., Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 1988. 140: 4245-4252.
19. Fiorentino, D. F., Bond, M. W. and Mosmann, T. R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989. 170: 2081-2095.
20. Mosmann, T. R. and Sad, S., The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol. Today 1996. 17: 138-146.
21. Li, X. Y., D'Orazio, T. J. and Niederkorn, J. Y., Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 1996. 89: 34-40.
22. Takeuchi, M., Kosiewicz, M. M., Alard, P. and Streilein, J. W., On the mechanisms by which transforming growth factor-beta-2 alters antigen-presenting abilities of macrophages on T cell activation. Eur. J. Immunol. 1997. 27: 1648-1656.
23. Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R. and Ferguson, T. A., CD95-induced apoptosis of lymphocytes in an immune privileged site induces Immunological tolerance. Immunity 1996. 5: 7-16.
24. D'Orazio, T. J. and Niederkorn, J. Y., A novel role for TGF-beta and IL-10 in the induction of immune privilege. J. Immunol. 1998. 160: 2089-2098.
25. Wilbanks, G. A., Mammolenti, M. and Streilein, J. W., Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur. J. Immunol. 1992. 22: 165-173.
26. Wilbanks, G. A. and Streilein, J. W., Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur. J. Immunol. 1992. 22: 1031-1036.
27. Streilein, J. W., Ksander, B. R. and Taylor, A. W., Immune deviation in relation to ocular immune privilege. J. Immunol. 1997. 158: 3557-3560.
28. Ferguson, T. A. and Herndon, J. M., The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen. Invest. Ophthalmol. Vis. Sci. 1994. 35: 3085-3093.
29. Streilein, J. W., Okamoto, S., Hara, Y., Kosiewicz, M. and Ksander, B., Blood-Borne Signals That Induce Anterior Chamber-Associated Immune Deviation After Intracameral Injection Of Antigen. Invest. Ophthalmol. Vis. Sci. 1997. 38: 2245-2254.
30. Anand, R. A., Ma, D., Alizadeh, H., Comerford, S. A., Sambrook, J. F., Gething, M.-J. H., McLean, I. W. and Niederkorn, J. Y, Characterization of intraocular tumors arising in transgenic mice. Invest. Ophthalmol. Vis. Sci. 1994. 35: 3533-3539.
31. Aaronson, S. A. and Todaro, G. J., Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science 1968. 162: 1024-1026.
32. Harding, C. V. and Song, R., Phagocytic Processing of Exogenous Particulate Antigens by Macrophages for Presentation by Class I MHC Molecules. J. Immunol. 1994. 153: 4925-4933.
33. Jampel, H. D., Roche, N., Stark, W. J. and Roberts, A. B., Transforming growth factor-beta in human aqueous humor. Curr. Eye Res. 1990. 9: 963-969.
34. Cousins, S. W., McCabe, M. M., Danielpour, D. and Streilein, J. W., Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 1991. 32: 2201-2211.
35. Granstein, R. D., Staszewski, R., Knisely, T. L., Zeira, E., Nazareno, R., Latina, M. and Albert, D. M., Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation [published erratum appears in J. Immunol. 1991. 146: 3687]. J. Immunol. 1990. 144: 3021-3027.